• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

外源性一氧化氮可抑制克里米亚-刚果出血热病毒。

Exogenous nitric oxide inhibits Crimean Congo hemorrhagic fever virus.

作者信息

Simon M, Falk K I, Lundkvist A, Mirazimi A

机构信息

Swedish Institute for Infectious Disease Control, SE-171 82 Solna, Sweden.

出版信息

Virus Res. 2006 Sep;120(1-2):184-90. doi: 10.1016/j.virusres.2006.03.005. Epub 2006 May 2.

DOI:10.1016/j.virusres.2006.03.005
PMID:16632039
Abstract

Crimean Congo hemorrhagic fever virus (CCHFV) is a geographically widespread pathogen that causes severe hemorrhagic fever with high mortality. Even though one of the main objectives focuses on the progress of antiviral agents, the research on CCHFV is strongly hampered due to its BSL-4 classification. Nitric oxide (NO), a mediator with broad biological effects, has been shown to possess inhibitory properties against various pathogens. The molecule constitutes a component of the innate immunity and serves to assist in the early immunological events where it contributes to clearance of microorganisms. In this study, we investigated the inhibitory properties of exogenous NO on CCHFV. We found that NO had a significant antiviral activity against CCHFV replication. By using the NO-donor S-nitroso-N-acetylpenicillamine (SNAP) we were able to show up to 99% reduction in virion progeny yield. In contrast, 3-morpholinosydnonimine hydrochloride (SIN-1), a peroxynitrite donor, had no significant antiviral activity against CCHFV. Furthermore the expression of viral proteins; the nucleocapsid protein and the glycoprotein, were clearly reduced with increasing concentrations of SNAP. We have also shown that the amount of total vRNA in SNAP-treated cells was reduced by about 50% compared to the controls.

摘要

克里米亚刚果出血热病毒(CCHFV)是一种在地理上广泛传播的病原体,可引起严重出血热,死亡率很高。尽管主要目标之一集中在抗病毒药物的进展上,但由于其生物安全4级分类,对CCHFV的研究受到了严重阻碍。一氧化氮(NO)是一种具有广泛生物学效应的介质,已被证明对多种病原体具有抑制特性。该分子是先天免疫的一个组成部分,有助于早期免疫事件,在其中促进微生物的清除。在本研究中,我们研究了外源性NO对CCHFV的抑制特性。我们发现NO对CCHFV复制具有显著的抗病毒活性。通过使用NO供体S-亚硝基-N-乙酰青霉胺(SNAP),我们能够使子代病毒粒子产量降低高达99%。相比之下,过氧亚硝酸盐供体盐酸3-吗啉代辛二亚胺(SIN-1)对CCHFV没有显著的抗病毒活性。此外,随着SNAP浓度的增加,病毒蛋白核衣壳蛋白和糖蛋白的表达明显降低。我们还表明,与对照组相比,SNAP处理细胞中的总病毒RNA量减少了约50%。

相似文献

1
Exogenous nitric oxide inhibits Crimean Congo hemorrhagic fever virus.外源性一氧化氮可抑制克里米亚-刚果出血热病毒。
Virus Res. 2006 Sep;120(1-2):184-90. doi: 10.1016/j.virusres.2006.03.005. Epub 2006 May 2.
2
Type I interferon inhibits Crimean-Congo hemorrhagic fever virus in human target cells.I型干扰素在人类靶细胞中抑制克里米亚-刚果出血热病毒。
J Med Virol. 2006 Feb;78(2):216-22. doi: 10.1002/jmv.20530.
3
Role of actin filaments in targeting of Crimean Congo hemorrhagic fever virus nucleocapsid protein to perinuclear regions of mammalian cells.肌动蛋白丝在将克里米亚刚果出血热病毒核衣壳蛋白靶向哺乳动物细胞的核周区域中的作用。
J Med Virol. 2004 Jan;72(1):83-93. doi: 10.1002/jmv.10560.
4
Crimean-Congo hemorrhagic fever virus delays activation of the innate immune response.克里米亚-刚果出血热病毒会延迟先天免疫反应的激活。
J Med Virol. 2008 Aug;80(8):1397-404. doi: 10.1002/jmv.21222.
5
Crimean-Congo hemorrhagic fever virus entry and replication is clathrin-, pH- and cholesterol-dependent.克里米亚-刚果出血热病毒的进入和复制依赖于网格蛋白、pH值和胆固醇。
J Gen Virol. 2009 Jan;90(Pt 1):210-5. doi: 10.1099/vir.0.006387-0.
6
Microtubule-dependent and microtubule-independent steps in Crimean-Congo hemorrhagic fever virus replication cycle.克里米亚-刚果出血热病毒复制周期中依赖微管和不依赖微管的步骤。
Virology. 2009 Mar 15;385(2):313-22. doi: 10.1016/j.virol.2008.11.020. Epub 2009 Jan 15.
7
In situ rolling circle amplification detection of Crimean Congo hemorrhagic fever virus (CCHFV) complementary and viral RNA.原位滚环扩增检测克里米亚-刚果出血热病毒(CCHFV)互补和病毒 RNA。
Virology. 2012 May 10;426(2):87-92. doi: 10.1016/j.virol.2012.01.032. Epub 2012 Feb 16.
8
Heat Shock Protein 70 Family Members Interact with Crimean-Congo Hemorrhagic Fever Virus and Hazara Virus Nucleocapsid Proteins and Perform a Functional Role in the Nairovirus Replication Cycle.热休克蛋白70家族成员与克里米亚-刚果出血热病毒和哈扎拉病毒核衣壳蛋白相互作用,并在奈罗病毒复制周期中发挥功能作用。
J Virol. 2016 Sep 29;90(20):9305-16. doi: 10.1128/JVI.00661-16. Print 2016 Oct 15.
9
Crimean-Congo hemorrhagic fever virus nucleocapsid protein harbors distinct RNA-binding sites in the stalk and head domains.克里米亚-刚果出血热病毒核衣壳蛋白在茎部和头部结构域具有独特的 RNA 结合位点。
J Biol Chem. 2019 Mar 29;294(13):5023-5037. doi: 10.1074/jbc.RA118.004976. Epub 2019 Feb 5.
10
Human MxA protein inhibits the replication of Crimean-Congo hemorrhagic fever virus.人Mx A蛋白可抑制克里米亚-刚果出血热病毒的复制。
J Virol. 2004 Apr;78(8):4323-9. doi: 10.1128/jvi.78.8.4323-4329.2004.

引用本文的文献

1
Nitric oxide and viral infection: Recent developments in antiviral therapies and platforms.一氧化氮与病毒感染:抗病毒疗法及平台的最新进展
Appl Mater Today. 2021 Mar;22:100887. doi: 10.1016/j.apmt.2020.100887. Epub 2020 Dec 5.
2
In silico design and analyses of a multi-epitope vaccine against Crimean-Congo hemorrhagic fever virus through reverse vaccinology and immunoinformatics approaches.基于反向疫苗学和免疫信息学方法对克里米亚-刚果出血热病毒的多表位疫苗进行计算机设计和分析。
Sci Rep. 2022 May 24;12(1):8736. doi: 10.1038/s41598-022-12651-1.
3
Multi-omics insights into host-viral response and pathogenesis in Crimean-Congo hemorrhagic fever viruses for novel therapeutic target.
对克里米亚-刚果出血热病毒的宿主-病毒反应和发病机制的多组学研究为新型治疗靶点提供了线索。
Elife. 2022 Apr 19;11:e76071. doi: 10.7554/eLife.76071.
4
NO in Viral Infections: Role and Development of Antiviral Therapies.病毒感染中的一氧化氮:抗病毒治疗的作用和发展。
Molecules. 2022 Apr 5;27(7):2337. doi: 10.3390/molecules27072337.
5
The potential role of inhaled nitric oxide for postexposure chemoprophylaxis of COVID-19.吸入一氧化氮在新型冠状病毒肺炎暴露后化学预防中的潜在作用。
J Genet Eng Biotechnol. 2021 Oct 22;19(1):165. doi: 10.1186/s43141-021-00249-5.
6
Nucleocapsid protein-based vaccine provides protection in mice against lethal Crimean-Congo hemorrhagic fever virus challenge.核衣壳蛋白基疫苗为小鼠提供针对致命性克里米亚-刚果出血热病毒挑战的保护。
PLoS Negl Trop Dis. 2018 Jul 16;12(7):e0006628. doi: 10.1371/journal.pntd.0006628. eCollection 2018 Jul.
7
Development of vaccines against Crimean-Congo haemorrhagic fever virus.抗克里米亚-刚果出血热病毒疫苗的研发
Vaccine. 2017 Oct 20;35(44):6015-6023. doi: 10.1016/j.vaccine.2017.05.031. Epub 2017 Jul 4.
8
Assessment of Inhibitors of Pathogenic Crimean-Congo Hemorrhagic Fever Virus Strains Using Virus-Like Particles.利用病毒样颗粒评估致病性克里米亚-刚果出血热病毒株的抑制剂
PLoS Negl Trop Dis. 2015 Dec 1;9(12):e0004259. doi: 10.1371/journal.pntd.0004259. eCollection 2015 Dec.
9
A virus-like particle system identifies the endonuclease domain of Crimean-Congo hemorrhagic fever virus.一种病毒样颗粒系统鉴定出克里米亚-刚果出血热病毒的核酸内切酶结构域。
J Virol. 2015 Jun;89(11):5957-67. doi: 10.1128/JVI.03691-14. Epub 2015 Mar 25.
10
Structure of Crimean-Congo hemorrhagic fever virus nucleoprotein: superhelical homo-oligomers and the role of caspase-3 cleavage.克里米亚-刚果出血热病毒核蛋白的结构:超螺旋同型寡聚物和半胱天冬酶-3 切割的作用。
J Virol. 2012 Nov;86(22):12294-303. doi: 10.1128/JVI.01627-12. Epub 2012 Sep 5.